The VKORC1 and CYP2C9 gene variants as pharmacogenetic factors in acenocoumarol therapy in Serbian patients - consideration of hypersensitivity and resistance
Introduction/Objective. Coumarin therapy represents one of the best models for applying pharmacogenetics. The contribution of factors influencing coumarin therapy can vary significantly between ethnic groups, which justifies conducting population-specific studies. The aim of this study was to analyz...
Main Authors: | Rakićević Ljiljana, Kovač Mirjana, Radojković Dragica, Radojković Milica |
---|---|
Format: | Article |
Language: | English |
Published: |
Serbian Medical Society
2022-01-01
|
Series: | Srpski Arhiv za Celokupno Lekarstvo |
Subjects: | |
Online Access: | http://www.doiserbia.nb.rs/img/doi/0370-8179/2022/0370-81792200013R.pdf |
Similar Items
-
A Pharmacogenetically Guided Acenocoumarol Dosing Algorithm for Chilean Patients: A Discovery Cohort Study
by: Angela Roco, et al.
Published: (2020-04-01) -
Genotype-phenotype correlations in patients treated with acenocoumarol / Corelaţii genotip-fenotip la pacienţii trataţi cu acenocumarol
by: Militaru Florentina Claudia, et al.
Published: (2014-09-01) -
Efficiency and effectiveness of the use of an acenocoumarol pharmacogenetic dosing algorithm versus usual care in patients with venous thromboembolic disease initiating oral anticoagulation: study protocol for a randomized controlled trial
by: Carcas Antonio J, et al.
Published: (2012-12-01) -
Acenocoumarol Pharmacogenetic Dosing Algorithm versus Usual Care in Patients with Venous Thromboembolism: A Randomised Clinical Trial
by: Hoi Yan Tong, et al.
Published: (2021-06-01) -
The Effect of CYP2C9 and VKORC1 Genetic Polymorphism on Warfarin Dose Requirements in a Sample of Iraqi Patients
by: Maha Ali Saleh, et al.
Published: (2021-03-01)